Bortenat 3.5 mg Injection
  1. Home
  2. Pharma Products
  3. Natco Pharma Ltd
  4. Bortenat 3.5 mg Injection

Bortenat 3.5 mg Injection

Bortenat 3.5 mg Injection contains bortezomib 3.5 mg, a proteasome inhibitor used as an anticancer medicine. It is used mainly for the treatment of multiple myeloma and mantle-cell lymphoma. The injection is administered by a qualified healthcare professional under medical supervision.

BUY NOW

Category

Bortezomib works by inhibiting proteasomes involved in protein breakdown, which can interfere with the survival and growth of certain cancer cells. It may be used alone or in combination with other medicines according to the prescribed oncology treatment protocol. Blood counts and clinical symptoms should be monitored because treatment may cause fatigue, nausea, reduced blood-cell counts, and peripheral neuropathy. The dosage and treatment schedule are individualized by the treating oncologist according to the patient’s condition and response to treatment.

Technical Specification

Specification Details
Active Ingredient Bortezomib
Strength 3.5 mg
Dosage Form Powder for Injection
Route of Administration Intravenous
Pack Size 1 Vial
Manufacturer / Marketer Natco Pharma Ltd

Product Also Known As

Bortenat 3.5 mg Injection, Bortenat 3.5mg Injection, Bortenat 3.5 mg Vial, Bortezomib 3.5 mg Injection, Bortezomib 3.5mg Injection, Bortezomib 3.5 mg Vial, Bortezomib Anticancer Injection